146961-76-4|Alatrofloxacin|7-((1R,5S,6s)-6-((S)-2-((S)-2-aminopropanamido)propanamido)-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid|-范德生物科技公司

Alatrofloxacin

NMR下载 COA and HPLC MSDS下载
names：
7-((1R,5S,6s)-6-((S)-2-((S)-2-aminopropanamido)propanamido)-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
CAS号：
146961-76-4
MDL Number：
MF(分子式)： C26H25F3N6O5 MW(分子量)： 558.51
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Alatrofloxacin
英文别名	Alatrofloxacin;
CAS号	146961-76-4
SMILES	C[C@H](N)C(N[C@H](C(N[C@H]1[C@H]2[C@@H]1CN(c(c(F)c3)nc4c3c(=O)c(C(O)=O)cn4c5c(F)cc(F)cc5)C2)=O)C)=O
Inchi	InChI=1S/C26H25F3N6O5/c1-10(30)24(37)31-11(2)25(38)32-20-14-7-34(8-15(14)20)23-18(29)6-13-21(36)16(26(39)40)9-35(22(13)33-23)19-4-3-12(27)5-17(19)28/h3-6,9-11,14-15,20H,7-8,30H2,1-2H3,(H,31,37)(H,32,38)(H,39,40)/t10-,11-,14-,15+,20+/m0/s1
InchiKey	UUZPPAMZDFLUHD-VUJLHGSVSA-N
分子式 Formula	C26H25F3N6O5
分子量 Molecular Weight	558.51
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Alatrofloxacin(CAS:146961-76-4):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Alatrofloxacin is a prodrug of trovafloxacin.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Mukherjee J. Post-approval translational research itself has diverse ethics. Am J Bioeth. 2010 Aug;10(8):43-4. doi: 10.1080/15265161.2010.496525. PubMed PMID: 20694908.

[2]Hsiao CJ, Younis H, Boelsterli UA. Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction. Chem Biol Interact. 2010 Oct 6;188(1):204-13. doi: 10.1016/j.cbi.2010.07.017. Epub 2010 Jul 23. PubMed PMID: 20655887.

[3] Annas GJ. Globalized clinical trials and informed consent. N Engl J Med. 2009 May 14;360(20):2050-3. doi: 10.1056/NEJMp0901474. PubMed PMID: 19439740.

[4] Ezeome ER, Simon C. Ethical problems in conducting research in acute epidemics: the Pfizer meningitis study in Nigeria as an illustration. Dev World Bioeth. 2010 Apr;10(1):1-10. doi: 10.1111/j.1471-8847.2008.00239.x. Epub 2008 Jul 28. PubMed PMID: 18665846.

[5] Jegede AS. Understanding informed consent for participation in international health research. Dev World Bioeth. 2009 Aug;9(2):81-7. doi: 10.1111/j.1471-8847.2008.00238.x. Epub 2008 Jul 15. PubMed PMID: 18637943.

6: Loewenberg S. Drug company trials come under increasing scrutiny. Lancet. 2008 Jan 19;371(9608):191-2. PubMed PMID: 18217230.7: Aagaard L, Soendergaard B, Stenver DI, Hansen EH. Knowledge creation about ADRs--turning the perspective from the rear mirror to the projector? Br J Clin Pharmacol. 2008 Mar;65(3):364-76. Epub 2007 Oct 24. PubMed PMID: 17961195; PubMed Central PMCID: PMC2291241.8: Willyard C. Pfizer lawsuit spotlights ethics of developing world clinical trials. Nat Med. 2007 Jul;13(7):763. Epub 2007 Jun 29. PubMed PMID: 17618250.9: Lenzer J. Secret report surfaces showing that Pfizer was at fault in Nigerian drug tests. BMJ. 2006 May 27;332(7552):1233. PubMed PMID: 16735322; PubMed Central PMCID: PMC1471980.10: Starr JA, Ragucci KR. Thrombocytopenia associated with intravenous ciprofloxacin. Pharmacotherapy. 2005 Jul;25(7):1030-4. PubMed PMID: 16006282.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开